PE20010238A1 - GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS SodC, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS - Google Patents
GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS SodC, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOSInfo
- Publication number
- PE20010238A1 PE20010238A1 PE2000000445A PE0004452000A PE20010238A1 PE 20010238 A1 PE20010238 A1 PE 20010238A1 PE 2000000445 A PE2000000445 A PE 2000000445A PE 0004452000 A PE0004452000 A PE 0004452000A PE 20010238 A1 PE20010238 A1 PE 20010238A1
- Authority
- PE
- Peru
- Prior art keywords
- polypeptide
- sodc
- amino acid
- cell
- acid sequence
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 11
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 8
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 241001469654 Lawsonia <weevil> Species 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 150000001413 amino acids Chemical group 0.000 abstract 4
- 108010038807 Oligopeptides Proteins 0.000 abstract 2
- 102000015636 Oligopeptides Human genes 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 230000001681 protective effect Effects 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 108010006464 Hemolysin Proteins Proteins 0.000 abstract 1
- 241001148567 Lawsonia intracellularis Species 0.000 abstract 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000003228 hemolysin Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
SE REFIERE A UN POLIPEPTIDO INMUNOGENICO AISLADO O RECOMBINANTE QUE IMITA, REACCIONA CON UN EPITOPE DE CELULA B O CELULA T DE UN POLIPEPTIDO, CAPAZ DE LOGRAR LA PRODUCCION DE ANTICUERPOS, CONFERIR UNA RESPUESTA INMUNE PROTECTORA CONTRA LAWSONIA SPP SodC TAL COMO LAWSONIA INTRACELLULARIS CUANDO SE ADMINISTRA A UN AVE, PORCINO; ES SELECCIONADO DE: a)UN PEPTIDO, OLIGOPEPTIDO, POLIPEPTIDO QUE COMPRENDE UNA SECUENCIA DE AMINOACIDOS QUE TIENE POR LO MENOS 70% DE IDENTIDAD DE SECUENCIA GENERAL CON LA SECUENCIA DE AMINOACIDO EN LA SEC ID NO:1 O LA SECUENCIA DE AMINOACIDOS CODIFICADA POR LA SECUENCIA DE NUCLEOTIDOS QUE CODIFICA EL SodC DE pALK13(ATCC 207196) ESENCIALMENTE LA SECUENCIA QUE CODIFICA EL SodC DE pALK14 (ATCC 207155); b)UN PEPTIDO, OLIGOPEPTIDO, POLIPEPTIDO QUE COMPRENDE UNA SECUENCIA DE AMINOACIDO QUE TIENE POR LO MENOS 50% DE IDENTIDAD GENERAL DE SECUENCIA CON LOS RESIDUOS 1 A 42 DE LA SEC ID NO:1; c)UN HOMOLOGO, ANALOGO, DERIVADO DE QUE IMITA UN EPITOPE DE CELULA B O CELULA T DE UN POLIPEPTIDO DE LAWSONIA SPP SodC. SE REFIERE TAMBIEN A UNA VACUNA QUE COMPRENDE ADEMAS UN SEGUNDO COMPONENTE INMUNOGENICO QUE COMPRENDE UN PEPTIDO, POLIPEPTIDO, PROTEINA ANTIGENICA DE L. INTRACELLULARIS TAL COMO OmpH, FlgE, HEMOLISINA, AUTOLISINA; UN VECTOR PARA VACUNA, MOLECULA AISLADA DE ACIDO NUCLEICO, PLASMIDO pALK14
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13398999P | 1999-05-13 | 1999-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010238A1 true PE20010238A1 (es) | 2001-03-03 |
Family
ID=22461256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000000445A PE20010238A1 (es) | 1999-05-13 | 2000-05-12 | GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS SodC, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1177212A4 (es) |
| JP (1) | JP2003501013A (es) |
| AR (1) | AR023975A1 (es) |
| AU (1) | AU4385800A (es) |
| BR (1) | BR0011292A (es) |
| CA (1) | CA2372095A1 (es) |
| MX (1) | MXPA01011670A (es) |
| NZ (1) | NZ515332A (es) |
| PE (1) | PE20010238A1 (es) |
| WO (1) | WO2000069903A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605696B1 (en) | 1999-10-22 | 2003-08-12 | Pfizer, Inc. | Lawsonia intracellularis proteins, and related methods and materials |
| EP1219711B1 (en) | 2000-12-20 | 2006-06-14 | Intervet International BV | Lawsonia intracellularis vaccine |
| DE602004024423D1 (de) | 2003-09-12 | 2010-01-14 | Intervet Int Bv | Impfstoff mit lawsonia intracellularis-untereinheit |
| KR20060134054A (ko) | 2004-01-22 | 2006-12-27 | 인터벳 인터내셔널 비.브이. | 로소니아 인트라셀룰라리스 서브유닛 백신 |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| US8398994B2 (en) | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
| EP2859900A1 (en) | 2006-12-11 | 2015-04-15 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
| CN111830257B (zh) * | 2020-07-17 | 2023-10-24 | 南京农业大学 | 一种猪源胞内劳森菌ipma抗原检测方法及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5885823A (en) * | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| US7022328B1 (en) * | 1995-11-30 | 2006-04-04 | Australian Pork Limited | Therapeutic and diagnostic compositions |
-
2000
- 2000-05-11 NZ NZ515332A patent/NZ515332A/xx unknown
- 2000-05-11 CA CA002372095A patent/CA2372095A1/en not_active Abandoned
- 2000-05-11 WO PCT/AU2000/000436 patent/WO2000069903A1/en not_active Application Discontinuation
- 2000-05-11 EP EP00924975A patent/EP1177212A4/en not_active Withdrawn
- 2000-05-11 MX MXPA01011670A patent/MXPA01011670A/es unknown
- 2000-05-11 AU AU43858/00A patent/AU4385800A/en not_active Abandoned
- 2000-05-11 BR BR0011292-5A patent/BR0011292A/pt not_active IP Right Cessation
- 2000-05-11 JP JP2000618319A patent/JP2003501013A/ja active Pending
- 2000-05-12 AR ARP000102294A patent/AR023975A1/es unknown
- 2000-05-12 PE PE2000000445A patent/PE20010238A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000069903A1 (en) | 2000-11-23 |
| CA2372095A1 (en) | 2000-11-23 |
| EP1177212A1 (en) | 2002-02-06 |
| NZ515332A (en) | 2004-01-30 |
| EP1177212A4 (en) | 2002-08-28 |
| AR023975A1 (es) | 2002-09-04 |
| BR0011292A (pt) | 2002-02-26 |
| JP2003501013A (ja) | 2003-01-14 |
| MXPA01011670A (es) | 2003-10-14 |
| AU4385800A (en) | 2000-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199800973A1 (ru) | Полипептид белка-106 наружной мембраны moraxella catarrhalis, последовательность гена и их применение | |
| IL133056A (en) | Polypeptide containing an immunogenic portion of an m. tuberculosis antigen, a variant thereof and pharmaceutical compositions containing same | |
| DE60332645D1 (de) | Ii-key/antigene epitop-hybrid-peptid-vakzine | |
| BRPI0412799A (pt) | imunógeno, composição, ácido nucleico, célula recombinante, métodos para preparar um polipeptìdeo, para induzir um a resposta imune protetora em um paciente e para induzir uma resposta anamnésica em um paciente, e, seqüência de ácido nucleico otimizada de levedura | |
| NZ331829A (en) | Clostridium perfringens vaccines | |
| TW200716166A (en) | Lawsonia intracellularis immunological proteins | |
| HU9203449D0 (en) | Varied cd44 surfacial proteins, dna sequences coding them, antibodies acting against these proteins as well as application of all these things in diagnostics and therapy | |
| SE9402089D0 (sv) | Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments | |
| PE20010238A1 (es) | GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS SodC, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS | |
| PE20231212A1 (es) | Polipeptidos variantes proteoliticamente estables de u1-agatoxina-ta1b para el control de plagas | |
| WO2002008716A3 (fr) | Procede de criblage de peptides utilisables en immunotherapie | |
| PE20010237A1 (es) | GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS OmpH, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS | |
| WO2003090667A3 (fr) | Composition immunogene ou vaccinale non immunosuppressive, comprenant une proteine e7 mutee du virus hpv-16 | |
| PE20010239A1 (es) | Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos | |
| ATE357526T1 (de) | Modifizierte hcv peptid-impfstoffe | |
| PE20010316A1 (es) | GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS, PEPTIDOS Y PROTEINAS FlgE RELACIONADOS Y SUS USOS | |
| CA2158024A1 (en) | A mycoplasma gallisepticum antigen, dna encoding the antigen, recombinant vector bearing the dna and recombinant virus utilizing the recombinant vector as well as use thereof | |
| BR0209854A (pt) | Molécula de ácido nucléico recombinante, cassete de expressão, vetor, polipeptìdeo, composição de vacina, dispositivo de aceleração de partìcula, e, método para gerar uma resposta imune celular em um indivìduo | |
| ATE312923T1 (de) | Moraxella catarrhalis basb034 polypeptide und verwendungen davon | |
| WO2004056316A8 (en) | Vaccines against hiv-1 tat protein to generate neutralizing antibodies | |
| NO20006456L (no) | En mutant human hepatitt B viral stamme og anvendelser derav | |
| DK43991A (da) | Allele varianter af plasmodium falciparum merozoitoverfladeantigen | |
| AR004191A1 (es) | Polipeptidos para inducir inmunidad protectora contra la tuberculosis, molecula de adn que los codifica, un vector de expresion, una celula huesped,una composicion farmaceutica, una vacuna, una proteina de fusion, un metodo para detectar la tuberculosis y kit de diagnostico. | |
| TH61176A (th) | กรดนิวคลีอิกที่ให้รหัสโพลีเพพไทด์ที่เกี่ยวกับการผ่านเข้าสู่เซลล์ของไวรัส prrs | |
| WO2001070774B1 (en) | Human t cell response to mhc-binding motif clusters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |